Revolution Medicines, Inc. - COM (RVMD)

Historical Portfolio Holders from Q1 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
158 M
Holdings value Q1 2024
$5.09 B
Value change Q1 2024
+$14.7 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
199
Number of buys Q1 2024
102
Number of sells Q1 2024
-86
Average buys Q1 2024 %
+0.008%
Average sells Q1 2024 %
-0.01%
CUSIP
76155X100
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 158 M $5.09 B +$14.7 M $32.23 200
2023 Q4 158 M $4.54 B +$1.16 B $28.68 186
2023 Q3 112 M $3.1 B +$8.76 M $27.68 166
2023 Q2 111 M $2.98 B +$99.9 M $26.75 137
2023 Q1 108 M $2.34 B +$421 M $21.66 147
2022 Q4 88.2 M $2.1 B +$33.1 M $23.82 131
2022 Q3 81 M $1.6 B +$213 M $19.72 127
2022 Q2 71 M $1.38 B +$38.1 M $19.49 121
2022 Q1 73.9 M $1.89 B +$15.7 M $25.51 121
2021 Q4 73.3 M $1.84 B -$50.2 M $25.17 111
2021 Q3 72.3 M $1.99 B +$49.8 M $27.51 111
2021 Q2 70.3 M $2.23 B +$90.8 M $31.74 125
2021 Q1 66.4 M $3.05 B +$427 M $45.88 125
2020 Q4 57.3 M $2.27 B +$131 M $39.59 114
2020 Q3 57 M $1.98 B +$340 M $34.80 87
2020 Q2 46.9 M $1.48 B +$22.7 M $31.57 72
2020 Q1 46.9 M $1.03 B +$1.02 B $21.91 71